Bristol-Myers Squibb (NYSE:BMY) said today that it has agreed to sell $1.5 billion of senior unsecured notes in an underwritten public offering.
The offering includes $750 million in 1.6% senior notes due in 2019 and $750 million in 3.3% senior notes due in 2027, according to the New York-based company.
Bristol-Myers said it plans to use the proceeds from the offering to fund its share repurchase program, as well as for general corporate purposes.
Get the full story at our sister site, Drug Delivery Business News.
The post Bristol-Myers prices $1.5B senior notes offering appeared first on MassDevice.
from MassDevice http://ift.tt/2lzo8db
Cap comentari:
Publica un comentari a l'entrada